X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs STERLING BIOTECH - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS STERLING BIOTECH J.B.CHEMICALS/
STERLING BIOTECH
 
P/E (TTM) x 14.0 -1.8 - View Chart
P/BV x 2.2 0.1 3,175.8% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   STERLING BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
STERLING BIOTECH
Dec-13
J.B.CHEMICALS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs31811 3,029.5%   
Low Rs2003 5,867.6%   
Sales per share (Unadj.) Rs148.026.8 552.0%  
Earnings per share (Unadj.) Rs19.1-15.0 -127.6%  
Cash flow per share (Unadj.) Rs23.9-5.5 -438.4%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.954.9 235.0%  
Shares outstanding (eoy) m84.82267.87 31.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.3 674.6%   
Avg P/E ratio x13.6-0.5 -2,918.4%  
P/CF ratio (eoy) x10.8-1.3 -849.5%  
Price / Book Value ratio x2.00.1 1,584.9%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,862 1,179.1%   
No. of employees `0002.71.4 201.9%   
Total wages/salary Rs m1,841547 336.7%   
Avg. sales/employee Rs Th4,590.95,303.3 86.6%   
Avg. wages/employee Rs Th673.4403.8 166.8%   
Avg. net profit/employee Rs Th592.1-2,959.0 -20.0%   
INCOME DATA
Net Sales Rs m12,5517,181 174.8%  
Other income Rs m54243 1,271.4%   
Total revenues Rs m13,0937,223 181.3%   
Gross profit Rs m2,055947 217.0%  
Depreciation Rs m4122,543 16.2%   
Interest Rs m964,377 2.2%   
Profit before tax Rs m2,088-5,931 -35.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469-1,924 -24.4%   
Profit after tax Rs m1,619-4,007 -40.4%  
Gross profit margin %16.413.2 124.1%  
Effective tax rate %22.532.4 69.2%   
Net profit margin %12.9-55.8 -23.1%  
BALANCE SHEET DATA
Current assets Rs m7,77814,335 54.3%   
Current liabilities Rs m4,35849,809 8.7%   
Net working cap to sales %27.2-494.0 -5.5%  
Current ratio x1.80.3 620.1%  
Inventory Days Days55403 13.6%  
Debtors Days Days80171 46.9%  
Net fixed assets Rs m5,71355,432 10.3%   
Share capital Rs m170268 63.3%   
"Free" reserves Rs m10,54713,935 75.7%   
Net worth Rs m10,93714,701 74.4%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m15,57473,988 21.0%  
Interest coverage x22.8-0.4 -6,429.0%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.1 830.4%   
Return on assets %11.00.5 2,197.7%  
Return on equity %14.8-27.3 -54.3%  
Return on capital %20.0-6.4 -310.7%  
Exports to sales %48.725.9 188.1%   
Imports to sales %7.10.2 4,167.4%   
Exports (fob) Rs m6,1151,860 328.8%   
Imports (cif) Rs m88912 7,284.4%   
Fx inflow Rs m6,1691,860 331.7%   
Fx outflow Rs m1,28525 5,163.2%   
Net fx Rs m4,8841,835 266.2%   
CASH FLOW
From Operations Rs m1,3971,719 81.3%  
From Investments Rs m-320-3,148 10.2%  
From Financial Activity Rs m-1,1961,426 -83.9%  
Net Cashflow Rs m-102-3 3,008.8%  

Share Holding

Indian Promoters % 55.4 33.9 163.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.0 -  
FIIs % 3.9 9.9 39.4%  
ADR/GDR % 0.0 16.9 -  
Free float % 37.0 39.3 94.1%  
Shareholders   30,437 21,482 141.7%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  STRIDES SHASUN LTD  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 23, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS